• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Undergraduate Honors Research
    • Undergraduate Honors Program - Economics Department
    • Vanderbilt Economics Department Honors Theses
    • View Item
    •   Institutional Repository Home
    • Undergraduate Honors Research
    • Undergraduate Honors Program - Economics Department
    • Vanderbilt Economics Department Honors Theses
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Understanding Effects of Pharmaceutical Price Control on Firms’ R&D Expenditure and Impacts on Social Welfare

    Huang, Shijia
    : http://hdl.handle.net/1803/17509
    : 2022-05-11

    Abstract

    Many studies have examined price regulations in the pharmaceutical industry in developed countries and found a negative relation between price control and pharmaceutical research and development (R&D). Nevertheless, the further impact of reduced pharmaceutical R&D spending on drug innovation has been less thoroughly studied. It is unclear whether the public benefits more from the controlled price or loses more from the reduced drug innovation in the future. Therefore, we are led to examine how the tradeoff between price cap and pharmaceutical R&D affects social welfare. By understanding price control's impact on future innovation and the market's demand, this research seeks to continue discussing whether the government should implement strict price control policies in the drug industry. Methodology: Based on 1084–2020 data for the U.S. pharmaceutical industry, we investigate the impact of price on the industry's R&D intensity. We estimate an aggregated R&D spending elasticity with which the industry responds to the pharmaceutical price level. We also establish a causal link between controlled pharmaceutical prices and consumer surplus in the market. A conceptual model is then used to compare drug innovation in the future with consumer savings at the current time and to discuss social welfare concerning the drug industry.
    Show full item record

    Files in this item

    Icon
    Name:
    Thesis_202205_SH.pdf
    Size:
    1.580Mb
    Format:
    PDF
    View/Open

    This item appears in the following collection(s):

    • Vanderbilt Economics Department Honors Theses

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy